DD244293A5 - Verfahren zur herstellung eines arzneimittels - Google Patents

Verfahren zur herstellung eines arzneimittels Download PDF

Info

Publication number
DD244293A5
DD244293A5 DD86286361A DD28636186A DD244293A5 DD 244293 A5 DD244293 A5 DD 244293A5 DD 86286361 A DD86286361 A DD 86286361A DD 28636186 A DD28636186 A DD 28636186A DD 244293 A5 DD244293 A5 DD 244293A5
Authority
DD
German Democratic Republic
Prior art keywords
flupirtine
combination
diclofenac
inflammatory
weight
Prior art date
Application number
DD86286361A
Other languages
German (de)
English (en)
Inventor
Ulrich Tibes
Carl H Weischer
Helmut Hettche
Hans-Peter Breuel
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD244293A5 publication Critical patent/DD244293A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD86286361A 1985-01-23 1986-01-21 Verfahren zur herstellung eines arzneimittels DD244293A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3502005 1985-01-23

Publications (1)

Publication Number Publication Date
DD244293A5 true DD244293A5 (de) 1987-04-01

Family

ID=6260451

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86286361A DD244293A5 (de) 1985-01-23 1986-01-21 Verfahren zur herstellung eines arzneimittels

Country Status (15)

Country Link
US (1) US4778799A (pt)
EP (1) EP0189788B1 (pt)
JP (1) JPH0623103B2 (pt)
AT (1) ATE46265T1 (pt)
AU (1) AU574557B2 (pt)
CA (1) CA1259260A (pt)
DD (1) DD244293A5 (pt)
DE (1) DE3665538D1 (pt)
DK (1) DK30486A (pt)
ES (1) ES8705762A1 (pt)
FI (1) FI860304A (pt)
GR (1) GR860178B (pt)
HU (1) HUT39603A (pt)
PT (1) PT81885B (pt)
ZA (1) ZA86481B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IN172468B (pt) * 1990-07-14 1993-08-14 Asta Medica Ag
DK0560092T3 (da) * 1992-03-11 1998-08-10 Asta Medica Ag Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
JP2920451B2 (ja) * 1993-03-29 1999-07-19 エスエス製薬株式会社 消炎鎮痛貼付剤
RU2002105502A (ru) * 1999-08-03 2004-03-20 АВД.фарма ГмбХ унд Ко. КГ (DE) Применение флупиртина для облегчения болей, вызванных дегенеративными заболеваниями суставов у собак и кошек
CA2443944A1 (en) * 2001-04-17 2002-10-31 Tanabe Seiyaku Co., Ltd. Agent for prophylaxis or treatment of inflammatory diseases in mucosa of oral cavity and the like
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
US7799832B2 (en) 2003-10-23 2010-09-21 Valeant Pharmaceuticals North America Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10359335A1 (de) * 2003-10-23 2005-05-25 Viatris Gmbh & Co. Kg Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
JP4800219B2 (ja) * 2003-12-16 2011-10-26 レレバーレ エーユーエスティー． ピーティーワイ リミテッド 方法および組成物
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
DK2061465T3 (da) 2006-08-23 2013-07-08 Valeant Pharmaceuticals Int Derivater af 4-(N-azacycloalkyl)anilider som kaliumkanalmodulatorer
US8993593B2 (en) 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
AU2007325629A1 (en) * 2006-11-28 2008-06-05 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
WO2011102460A1 (ja) * 2010-02-19 2011-08-25 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法
DE102010063609A1 (de) * 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
DE102010063612A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
DE3369315D1 (en) * 1982-10-27 1987-02-26 Degussa Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)

Also Published As

Publication number Publication date
ATE46265T1 (de) 1989-09-15
JPS61172819A (ja) 1986-08-04
FI860304A0 (fi) 1986-01-22
AU5260486A (en) 1986-07-31
ES551119A0 (es) 1987-05-16
HUT39603A (en) 1986-10-29
PT81885B (pt) 1987-11-30
US4778799A (en) 1988-10-18
DK30486A (da) 1986-07-24
DE3665538D1 (en) 1989-10-19
EP0189788A1 (de) 1986-08-06
GR860178B (en) 1986-05-23
EP0189788B1 (de) 1989-09-13
DK30486D0 (da) 1986-01-21
CA1259260A (en) 1989-09-12
ZA86481B (en) 1986-10-29
JPH0623103B2 (ja) 1994-03-30
FI860304A (fi) 1986-07-24
PT81885A (de) 1986-02-01
ES8705762A1 (es) 1987-05-16
AU574557B2 (en) 1988-07-07

Similar Documents

Publication Publication Date Title
DD244293A5 (de) Verfahren zur herstellung eines arzneimittels
DE69431568T2 (de) Inhibierung der migration und proliferation glatter muskeln mit hydroxycarbazolverbindungen
EP0467164B1 (de) Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen
DE60118547T2 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
JP2991733B2 (ja) 乾癬疾患を抑制するための薬剤及びその製法
EP0193056B1 (de) Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
DE3036367A1 (de) Wasserloesliche derivate von nichtsteroiden entzuendungshemmenden mitteln, und verfahren zur herstellung solcher derivate, sowie solche derivate enthaltende therapheutische zubereitungen
EP0241809A1 (de) Synergistische Kombination von Amantadin und Selegilin
DD291925A5 (de) Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
KR20010021865A (ko) 카파 작용제 항소양성 약학적 조성물 및 이를 이용한소양증의 치료 방법
JP2003526594A (ja) カッパ・アゴニスト抗掻痒薬学的製剤およびそれにより掻痒を治療する方法
RU2015128265A (ru) Способы лечения зуда
EP0752246A2 (de) Kappa-Opiate für entzündliche Darmerkrankungen
DE68903092T2 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DE3390116T1 (de) Verbesserte, Koffein enthaltende, analgetisch und antiinflammatorische Mittel und Verfahren für ihre Verwendung
DE3604575A1 (de) Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
DD267187A5 (de) Verfahren zur herstellung von mitteln zur bekaempfung des asthma bronchiale und der chonisch obstruktiven bronchitis
DE69209140T2 (de) Verwendung Glycine/NMDA-Rezeptorliganden zur Herstellung eines Arzneimittels zur Behandlung von Drogenabhängigkeit und Entzugserscheinungen
DE60219940T2 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
JPH06192107A (ja) グリチルリチン経口剤
US4898860A (en) Anticonvulsant composition and method
DE3780577T2 (de) Entzuendungshemmende zusammensetzungen.
DE69522764T2 (de) Verwendung vom einem Bicycloheptan-Derivat
DE3601195A1 (de) Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika
DE2328060A1 (de) Benzo- eckige klammer auf b eckige klammer zu -thiophenderivate und verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate